Minnesota Administrative Rules
Agency 151 - Labor and Industry Department
Chapter 5223 - DISABILITY SCHEDULES
DATES OF INJURY ON OR AFTER JULY 1, 1993
Part 5223.0620 - ENDOCRINE

Universal Citation: MN Rules 5223.0620

Current through Register Vol. 48, No. 39, March 25, 2024

Subpart 1. General.

For permanent partial impairment due to endocrine disease, the disability of the whole body is as provided in subparts 2 to 5. For evaluation purposes, the following are considered separately:

A. hypothyroidism;

B. hypoparathyroidism;

C. hypoadrenalism; and

D. hypoinsulinism.

Any permanent partial impairment to other body parts or organs directly resulting from any of these endocrine disorders must be rated as provided in the appropriate parts of this schedule. These ratings may be combined with each other and with any ratings under this part as described in part 5223.0300, subpart 3, item E.

Subp. 2. Thyroid; hypothyroidism.

History of signs or symptoms of thyroid insufficiency substantiated by objective tests, and there is anatomic loss or alteration, and persisting for 12 months:

A. signs or symptoms resolved with chronic replacement therapy, zero percent;

B. signs or symptoms cannot be fully resolved with replacement therapy, 15 percent.

Subp. 3. Parathyroid; hypoparathyroidism.

History of signs or symptoms of parathyroid insufficiency substantiated by objective tests, and there is anatomic loss or alteration, and persisting:

A. normal calcium level maintained by replacement therapy, zero percent;

B. normal calcium level cannot be maintained despite replacement therapy, ten percent.

Subp. 4. Adrenal; hypoadrenalism.

History of signs or symptoms of adrenal insufficiency substantiated by objective tests, and there is anatomic loss or alteration, and persisting:

A. signs or symptoms resolved with replacement therapy, zero percent;

B. signs or symptoms cannot be consistently controlled with replacement therapy, 15 percent.

Subp. 5. Insulin; hypoinsulinism.

History of signs or symptoms of insulin deficiency substantiated by objective tests, and there is anatomic loss or alteration to the islets of Langerhans, and persisting:

A. signs or symptoms controlled with diet alone, two percent;

B. signs or symptoms controlled with oral medication and diet, four percent;

C. signs or symptoms controlled with insulin and diet, 15 percent;

D. signs or symptoms inadequately controlled despite treatment with insulin and diet, 25 percent.

Statutory Authority: MS s 176.105

Disclaimer: These regulations may not be the most recent version. Minnesota may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.